参考文献/References:
[1] 王建旗.炎症预测和预防动脉粥样硬化性心血管事件的研究进展[J].心血管病学进展,2018,39(5):687-690.
[2] Lu L,Zhang RY,Wang XQ,et al.C1q/TNF-related protein-1:an adipokine marking and promoting atherosclerosis[J].Eur Heart J,2016,37(22):1762-1771.
[3] Apostolakis S,Vogiatzi K,Amanatidou V,et al.Interleukin 8 and cardiovascular disease[J].Cardiovasc Res,2009,84(3):353-360.
[4] Nymo SH, Hulthe J, Ueland T,et al.Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome.Results from CORONA[J].Eur J Heart Fail,2014,16(1):68-75.
[5] Deforge LE,Fantone JC,Kenney JS,et al.Oxygen radical scavengers selectively inhibit inter-leukin 8 production in human whole blood[J].J Clin Invest,1992,90(5):2123-2129.
[6] Marques P, Collado A, Martinez-Hervas S,et al.Systemic inflammation in metabolic syndrome: increased platelet and leukocyte activation, and key role of CX3CL1/CX3CR1 and CCL2/CCR2 axes in arterial platelet-proinflammatory monocyte adhesion[J].J Clin Med,2019,8(5):1-19.
[7] Rus HG,Vlaicu R,Niculescu F.Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall[J].Atherosclerosis,1996,127(2):263-271.
[8] Boekholdt SM,Peters RJ,Hack CE,et al.IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women:the EPIC-Norfolk prospective population study[J].Arterioscler Thromb Vasc Biol,2004,24(8):1503-1508.
[9] Herder C,Baumert J,Thorand B,et al.Chemokines and incident coronary heart disease:results from the MONICA/KORA Augsburg case-cohort study,1984-2002[J].Arterioscler Thromb Vasc Biol,2006,26(9):2147-2152.
[10] Zhang RJ,Li XD,Zhang SW,et al.IL-8 -251A/T polymorphism contributes to coronary artery disease susceptibility in a Chinese population[J].Genet Mol Res,2017,16(1):1-7.
[11] Zhang SR,Gao Y,Huang JY.Interleukin-8 gene -251 A/T (rs4073) polymorphism and coronary artery disease risk:a meta-analysis[J].Med Sci Monit,2019,25:1645-1655.
[12] Ren BJ,She Q.Study on the association between IL-1β,IL-8 and IL-10 gene polymorphisms and risk of coronary artery disease[J].Int J Clin Exp Med,2015,8(5):7937-7943.
[13] Zhang X,Zhang B,Zhang M,et al.Interleukin-8 gene polymorphism is associated with acute coronary syndrome in the Chinese Han population[J].Cytokine,2011,56(2):188-191.
[14] Caroselli C,de Rosa R, Tanzi P,et al.Endothelial immunomediated reactivity in acute cardiac ischaemia:role of endothelin 1,interleukin 8 and NT-proBNP in patients affected by unstable angina pectoris[J].Int J Immunopathol Pharmacol,2016,29(3):516-522.
[15] Correia LCL, Andrade BB, Borges VM,et al.Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes[J].Clin Chim Acta,2010,411(7):540-545.
[16] Liu ZX,Zhang MY,Wu J,et al.Serum CD121a(lnterleukin 1 receptor, type I):a potential novel inflammatory marker for coronary heart disease[J].PL oS One,2015,10(6):e0131086.
[17] Tziakas DN,Chalikias GK,Tentes IK,et al.Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome[J].Eur Heart J,2008,29(22):2713-2722.
[18] Inoue T,Komoda H,Nonaka M,et al.Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease[J].Int J Cardiol,2008,124(3):319-325.
[19] Qi XY,Li SR,Li JY.The prognostic value of IL-8 for cardiac events and restenosis in patients with coronary heart diseases after percutaneous coronary intervention[J].Jpn Heart J,2003,44(5):623-632.
[20] Cavusoglu E,Marmur JD,Yanamadala S,et al.Elevated baseline plasma IL-8 levels are an independent predictor of long-term all-cause mortality in patients with acute coronary syndrome [J]. Atherosclerosis,2015,242(2):589-594.
[21] Dominguez RA,Abreu GP,Garcia GM,et al.Prognostic value of interleukin-8 as a predictor of heart failure in patients with myocardial infarction and percutaneous intervention[J].Int J Cardiol, 2006,111(1):158-160.
[22] Shetelig C,Limalanathan S,Hoffmann P,et al.Association of IL-8 with infarct size and clinical outcomes in patients with STEMI[J].J Am Coll Cardiol,2018,72(2):187-198.
[23] Bekkering S,Quintin J,Joosten LAB,et al.Oxidized low-density lipoprotein induces long-term pro-inflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes[J].Arterioscler Thromb Vasc Biol,2014,34(8):1731-1738.
[24] Huo Y,Weber C,Forlow SB,et al.The chemokine KC,but not monocyte chemoattractant protein-1,triggers monocyte arrest on early atherosclerotic endothelium[J].J Clin Invest,2001,108(9):1307-1314.
[25] Gerszten RE,Garcia-Zepeda EA,Lim YC,et al.MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions[J].Nature,1999,398(6729):718-723.
[26] Boisvert WA,Santiago R,Curtiss LK,et al.A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice[J].J Clin Invest,1998,101(2):353-363.
[27] Tabas I, Bornfeldt KE.Macrophage phenotype and function in different stages of atherosclerosis[J].Circ Res,2016,118(4):653-667.
[28] Tang HP, Sun LX,Han W.Endothelial cells on the proliferation and expression of intercellular adhesion molecule 1 and interleukin 8 of vascular smooth muscle cells[J].Genet Mol Res,2013,12(4):4363-4370.
[29] Huang A,Patel S,McAlpine CS,et al.The role of endoplasmic reticulum stress-glycogen synthase kinase-3 signaling in atherogenesis[J].Int J Mol Sci,2018,19(6):1607-1620.
[30] Johnson JL.Metalloproteinases in atherosclerosis[J].Eur J Pharmacol,2017,816:93-106.
[31] Moreau M,Brocheriou I,Petit L,et al.Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages relevance to stability of atherosclerotic plaque[J].Circulation,1999,99:420-426.
[32] Gonzalez-Aparicio M,Alfaro C.Influence of lnterleukin-8 and neutrophil extracellular trap (NET) formation in the tumor microenvironment:is there a pathogenic role?[J] J Immunol Res,2019,2019:6252138.
[33] Simonini A,Moscucci M,Muller DW,et al.IL-8 is an angiogenic factor in human coronary atherectomy tissue[J].Circulation,2000,101(13):1519-1526.
[34] Naruko T,Ueda M,Haze K,et al.Neutrophil infiltration of culprit lesions in acute coronary syndromes[J].Circulation,2002,106(23):2894-2900.
[35] Distelmaier K,Winter MP, Dragschitz F, et al.Prognostic value of culprit site neutrophils in acute coronary syndrome[J].Eur J Clin Invest,2014,44(3):257-265.
[36] Schomig K,Busch G,Steppich B,et al.Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction[J].Eur Heart J,2006,27(9):1032-1037.
[37] Boyle EM,Kovacich JC,Hèbert CA.Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury[J].J Thorac Cardiovasc Surg,1998,116(1):114-121.
[38] Husebye T,Eritsland J,Arnesen H,et al.Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure[J].PLoS One,2014,9(11):e112359.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(8):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(8):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(8):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(8):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]李乐亮,综述,李萍,等.炎症标志物与颈动脉粥样斑块的稳定性[J].心血管病学进展,2016,(3):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
LI Leliang,LI Ping.Stability of Inflammatory Markers and Carotid Artery Plaque[J].Advances in Cardiovascular Diseases,2016,(8):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
[6]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(8):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[7]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(8):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[8]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(8):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[9]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(8):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[10]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[11]林春尧 刘晓辉.IL-33/ST2在冠心病中的研究进展[J].心血管病学进展,2020,(2):128.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.007]
LIN Chunyao LIU Xiaohui.IL-33/ST2 in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2020,(8):128.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.007]
[12]孙吉 江洪 余锂镭.外周动脉疾病与冠心病的相关性研究进展[J].心血管病学进展,2022,(8):702.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.009]
SUN Ji,JIANG Hong,YU Lilei?/html>.Correlation Between Peripheral Artery Disease?nd Coronary Artery Heart Disease[J].Advances in Cardiovascular Diseases,2022,(8):702.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.009]
[13]覃思润 盛喆 陈晨阳 詹耀坤 曹宇.中性粒细胞胞外在冠心病进展中的作用及机制研究[J].心血管病学进展,2023,(12):1088.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.008]
QIN Sirun,SHENG Zhe,CHEN Chenyang,et al.The Role and Mechanism of Neutrophil Extracellular Traps?n the Progression of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2023,(8):1088.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.008]